Boehringer Ingelheim RCV: Making lived behaviors visible with Eigenland

Let’s talk behaviors
Boehringer Ingelheim is a leading global pharmaceutical company with sales of €2.16 billion and 4,900 employees. The Vienna campus is home to 3,450 employees working in international teams. They develop therapies for humans and animals. Innovation, responsibility, and collaboration shape everyday work—across functions, countries, and disciplines.

The Path 2035 is clear – how should we behave now?

The gap between written and lived behaviors is evident in every company. This is because behavior is based on assumptions that have made people successful in the past. If you want to change behaviors, you have to “drill down” into the assumptions from the past and give the desired new behavior patterns a stage. Only then will they be perceived as “successful,” copied step by step, and ultimately become part of the culture.

Eigenland® – makes culture visible and activates solution competence

When I, as a consultant, am given a time slot of 1 hour and 45 minutes at an executive conference to work with 150 people in one room at the same time, Eigenland is my tool of choice. The method is based on small groups of 10 people who are placed in the room as often as desired. In our case here, we had 15 tables with 15 game sets, 15 tablets, and 15 printers.

At the heart of the intervention are theses that are developed in advance by a small preparation team. They are printed on discs and evaluated at the tables. Participants express their agreement or disagreement with “gemstones.” The results are transferred to the respective iPad by the table moderators. Within minutes, the table results are statistically evaluated. The discussion can begin.
The tables cluster their results according to diamonds, clouds, and storm warnings. In the last third of the time, each table designs an idea profile to positively address one of the clouds or storm warnings. Large initiatives and clever guerrilla ideas are the output after 115 minutes.
If you want to know what Boehringer Ingelheim has planned and how it went, come to one of our Power Hours.